Tackling overprescribing
- PMID: 34670733
- DOI: 10.1136/bmj.n2539
Tackling overprescribing
Conflict of interest statement
Competing interests: The BMJ has judged that there are no disqualifying financial ties to commercial companies. The authors declare the following other interests: FAM is senior medical adviser to the British National Formulary and chair of its joint formulary committee. Further details of The BMJ policy on financial interests is here: https://www.bmj.com/sites/default/files/attachments/resources/2016/03/16-current-bmj-education-coi-form.pdf.
Comment in
-
Some ways to tackle overprescribing.BMJ. 2021 Nov 30;375:n2951. doi: 10.1136/bmj.n2951. BMJ. 2021. PMID: 34848504 No abstract available.